One of the most important principles of sound investment management is staying on top of what’s happening in the world and how those events affect finances. Conditions change quickly, and keeping up-to-date on developments and trends can be challenging. The team of experts producing IWB have been advising Canadian investors for over 25 years.
Edited and Published by Gordon Pape. Associate Editor: Richard Croft
With Gavin Graham, Ryan Irvine, Glenn Rogers, Shawn Allen, Adam Mayers, Paul Bamford & Michael Corcoran.
Recent Issues
iwb20108 (February 22, 2010)
What’s an ETF?… Ryan Irvine picks a Chinese construction stock… Ryan Irvine updates Cash Store Financial… TFSA test… Retirement savings: Don’t be too conservative… Gordon Pape’s updates: Canadian Utilities, Penn West Energy… Your questions: First Highland Trust, cashing out RRSPs… Spam warning
iwb20107 (February 15, 2010)
A time to stand tall… Glenn Rogers: How to profit from doom and gloom… Glenn Rogers picks two mining giants… Glenn Rogers updates Agrium, Monsanto, ProShares Basic Materials ETF… Gordon Pape’s updates: EnCana, Cenovus Energy, Yellow Pages… Your Questions: Sector allocation…
iwb20106 (February 8, 2010)
Deficit angst… The markets: short-term gain, long-term pain… Webcasts to watch… Trust about-face… Tom Slee: RRSPs our last, best hope… The ETF universe expands – sort of… Your Questions: Rebalancing dilemma… Members’ Corner: SRI policy
iwb20105 (February 1, 2010)
Socially-responsible investing… Two good SRI funds… Irwin Michael: Watch for M&A to spark markets… Irwin Michael updates Canam Group, Danier Leather, Daylight Resources Trust, Cogeco… Other updates: Stantec, Finning, Rogers, Thomson Reuters… TFSA talk… Your Questions: TFSAs, global investing, RRSPs
Recent Updates
Pfizer Inc. (NYSE: PFE)
Pfizer is a leading international pharmaceutical company that can trace its history back more than 170 years. Its business units include Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines, and Internal Medicine. Pfizer was the first company (along with partner BioNTech) to have a Covid vaccine approved for general use. It has proven to be highly effective with minimal side effects. The company has also developed a drug to treat the virus.
Hold
Winpak Ltd. (TSX: WPK, OTC: WIPKF)
Winpak produces goods that are mainly used in the food and beverage and healthcare industries. Its modified atmosphere packaging is used to extend the shelf life of perishable products such as meat, poultry, and cheese as well as healthcare products. The majority of its sales are in North America.
Buy
Cameco Corp. (TSX: CCO, NYSE: CCJ)
Cameco is one of the world’s largest uranium producers, with mines at McArthur River and Cigar Lake in Saskatchewan and refineries in Ontario. As governments and investors have become more favourably inclined towards non-carbon emitting sources of baseload power such as nuclear in recent years, Cameco’s fortunes and its share price have revived.
Sell half
CGI Group (TSX: GIB.A, NYSE: GIB)
CGI is the fifth largest independent information technology and business process services firm in the world. The company, founded in 1976, delivers an end-to-end portfolio of capabilities, from IT and business consulting to systems integration, outsourcing services, and intellectual property solutions. It employs about 93,000 professionals in offices and delivery centres across the Americas, Europe, and the Asia Pacific region.
Hold
Bank of Nova Scotia (TSX, NYSE: BNS)
Scotiabank is the most internationally diversified of the major Canadian banks, with over 30% of its assets coming from its overseas operations, primarily what the bank describes as the three Pacific Alliance countries of Mexico, Peru, and Chile. It sold its subscale operations in Colombia, Panama, and Costa Rica to bank Davivienda in the first quarter in exchange for a 20% stake in Davivienda, taking a $1.4 billion impairment charge on the sale. Scotiabank has strengths in mortgage and corporate lending and wealth management and is usually the lowest cost operator amongst the major banks.